713143-67-0 Usage
General Description
"5-(3-Fluorophenyl)-2-methyl-pyridin" is a specific chemical compound which belongs to the category of organic compounds known as pyridines and derivatives. These are compounds containing a pyridine ring, which is a six-membered aromatic heterocycle with one nitrogen atom replacing a carbon atom. The unique characteristic of this compound is the substitution with a fluorphenyl group and a methyl group. The fluorine atom gives the phenyl group more electronegativity which might influence its behavior in chemical reactions. Currently, there is limited research on this specific molecule, and its potential applications or risks are not definitively known. Like other organic compounds, handling and usage of this compound should be done in a controlled environment while following appropriate safety measures.
Check Digit Verification of cas no
The CAS Registry Mumber 713143-67-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,3,1,4 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 713143-67:
(8*7)+(7*1)+(6*3)+(5*1)+(4*4)+(3*3)+(2*6)+(1*7)=130
130 % 10 = 0
So 713143-67-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H10FN/c1-9-5-6-11(8-14-9)10-3-2-4-12(13)7-10/h2-8H,1H3
713143-67-0Relevant articles and documents
Discovery of Potent Orally Active Protease-Activated Receptor 1 (PAR1) Antagonists Based on Andrographolide
Liu, Jun,Sun, Bin,Zhao, Xiaoyu,Xing, Jie,Gao, Yanhui,Chang, Wenqiang,Ji, Jianbo,Zheng, Hongbo,Cui, Changyi,Ji, Aiguo,Lou, Hongxiang
, p. 7166 - 7185 (2017/09/07)
Protease-activated receptor-1 (PAR1), a G-protein-coupled receptor, plays a critical role in thrombin-mediated platelet aggregation. It is regarded as a promising antithrombosis target that is unlikely to result in bleeding. Here, we describe the synthesi
[6+5] FUSED BICYCLES AS A THROMBIN ANTAGONIST, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE BICYCLES
-
, (2012/01/14)
The present invention relates to the new [6+5] fused bicycle derivatives, pharmaceutically acceptable salts or isomers thereof, processes for preparing the same, and pharmaceutical compositions comprising the same. The [6+5] fused bicycle derivatives can antagonize the thrombin receptor and thus may be effectively used for the treatment and prevention of thrombus, platelet aggregation, atherosclerosis, restenosis, blood coagulation, hypertension, arrhythmia, angina pectoris, heart failure, inflammation and cancer when used alone or with other cardiovascular agents.
